Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05297838 · ClinicalTrials.gov registry record · NA

Stationary Bike Use During Ice Bath and Virtual Reality

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
151
Enrollment target

NCT05297838: Completed NA study, sponsored by Stanford University.

NCT05297838 is a NA study that has completed, run by Stanford University. The registered enrollment target is 151 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05297838, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
151 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effectiveness of different technologies, in particular Virtual Reality, inclusive of passive content, active content, cognitive load modulation, and positive encouragement coaching to increase the pain threshold as assessed by immersing a hand in ice water while utilizing a stationary bike.

Primary Outcome

Pain Scores will be collected during ice bath (maximum of 4 minutes) every 30 seconds via numeric rating scale (NRS), 0 being no pain, 10 being worst pain imaginable

Interventions

  • OTHER Ice Bath
  • OTHER Stationary Bike
  • OTHER Virtual Reality (VR) Headset

Trial Details

FieldValue
Enrollment Target 151 participants
Start Date 2022-07-25
Est. Completion 2023-01-26
Phase NA
Stanford University

1,744 total trials

What the finished NCT05297838 record still lists

NCT05297838 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 3 interventions - of which Ice Bath is the first listed.

NCT05297838 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05297838 about?

NCT05297838 is a clinical study titled "Stationary Bike Use During Ice Bath and Virtual Reality". The purpose of this study is to evaluate the effectiveness of different technologies, in particular Virtual Reality, inclusive of passive content, active content, cognitive load modulation, and positive encouragement coaching to increase the pain threshold as assessed by immersing a hand in ice wate...

What is the current status of trial NCT05297838?

This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2022-07-25. Estimated completion is 2023-01-26.

What interventions are being tested in trial NCT05297838?

The interventions under investigation include: Ice Bath (OTHER), Stationary Bike (OTHER), Virtual Reality (VR) Headset (OTHER).

Who is sponsoring clinical trial NCT05297838?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05297838's enrollment target sits among peer trials

151 661st of 2000 higher than 1,340 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01409161 · 151 participants · Phase 2

    Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

  • NCT04245397 · 151 participants · Phase 1

    Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

  • NCT05761223 · 151 participants · Phase 1

    A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849

  • NCT07195656 · 151 participants · NA

    Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05297838, the US trial registry maintained by the National Library of Medicine. NCT05297838 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.